InfoBionics develops the cloud-based MoMe System and a Class 2 medical device aimed at detecting cardiac arrhythmias. The company says MoMe enables a seamless transition between holter, event, and mobile cardiac telemetry monitoring modes. The platform is also intended to track other chronic conditions. InfoBionics is led by Nancy Briefs and is preparing to roll out the first application of its Class 2 device later this year. The company completed the first tranche of a $17 million Series B as it raises fresh capital to support commercialization. The cardiac monitoring industry is cited in the article as an approximately $3 billion market, and digital medical devices attracted $146 million in venture investment last year.

Total raised

$17M

Funding rounds

1

Latest round

Series B

Latest activity

Apr 2014